Skip to content
Screener

uniQure QURE Investing Cash Flow

Investing Cash Flow at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$93.37M
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$3.02M-715%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$93.74M+49.2%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
-$7.59M-196%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
-$675K-22,400%
Regenxbio logo
RegenxbioRGNX
$65.93M+147%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Proceeds on maturity of debt securities384,981213,763
Investments in debt securities(232,550)(120,205)
Purchases of property, plant, and equipment(612)(386)
Net cash generated from investing activities151,81993,172
Cash flows from financing activities
Proceeds from follow-on public offering of ordinary shares, net of issuance costs242,68180,511
Proceeds from issuance of ordinary shares related to employee stock options and purchase plans6,985203
Net cash generated from financing activities249,66680,714

Item 1.Financial Statements

FAQ

What is uniQure's investing cash flow?
uniQure (QURE) reported investing cash flow of $53.26M in Q2 2026.
How has uniQure's investing cash flow changed year-over-year?
uniQure's investing cash flow decreased by 27.1% year-over-year, from $73.07M to $53.26M.
What is the long-term trend for uniQure's investing cash flow?
Over 2 years (2021 to 2025), uniQure's investing cash flow has grown at a 118.5% compound annual growth rate (CAGR), from -$67.39M to -$321.62M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about uniQure's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude